Cargando…

Is Metabolism of (R)-Ketamine Essential for the Antidepressant Effects?

Detalles Bibliográficos
Autor principal:	Chaki, Shigeyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793837/ https://www.ncbi.nlm.nih.gov/pubmed/29294032 http://dx.doi.org/10.1093/ijnp/pyx120

Ejemplares similares

Is the History Repeated? Can (2R,6R)-Hydroxynorketamine be Another Antidepressant?
por: Chaki, Shigeyuki, et al.
Publicado: (2018)

Beyond Ketamine: New Approaches to the Development of Safer Antidepressants
por: Chaki, Shigeyuki
Publicado: (2017)

Activation of σ1-Receptors by R-Ketamine May Enhance the Antidepressant Effect of S-Ketamine
por: Kalkman, Hans O.
Publicado: (2023)

No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model
por: Chang, Lijia, et al.
Publicado: (2018)

Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine
por: Chaki, Shigeyuki, et al.
Publicado: (2019)

Role of 5-HT(1A) Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine
por: Fukumoto, Kenichi, et al.
Publicado: (2017)

Does the Opioid System Block or Enhance the Antidepressant Effects of Ketamine?
por: Mathew, Sanjay J., et al.
Publicado: (2019)

Vasopressin V(1B) Receptor Antagonists as Potential Antidepressants
por: Chaki, Shigeyuki
Publicado: (2021)

Immunoregulation and antidepressant effect of ketamine
por: Zhang, Nan, et al.
Publicado: (2021)

Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants
por: Chaki, Shigeyuki, et al.
Publicado: (2015)

Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
por: Dong, Chao, et al.
Publicado: (2016)

Targeting of Metabotropic Glutamate Receptors for the Development of Novel Antidepressants
por: Chaki, Shigeyuki, et al.
Publicado: (2019)

Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
por: Zhang, Kai, et al.
Publicado: (2020)

The role of dissociation in ketamine’s antidepressant effects
por: Ballard, Elizabeth D., et al.
Publicado: (2020)

Ketamine’s antidepressant effect is mediated by energy metabolism and antioxidant defense system
por: Weckmann, Katja, et al.
Publicado: (2017)

Ketamine: stimulating antidepressant treatment?
por: Malhi, Gin S., et al.
Publicado: (2016)

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
por: Browne, Caroline A., et al.
Publicado: (2013)

Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model
por: Zhang, Kai, et al.
Publicado: (2018)

Structural Integrity in the Sustained Antidepressant Effect of Ketamine
por: Belujon, Pauline
Publicado: (2017)

Essential role of microglia in the fast antidepressant action of ketamine and hypidone hydrochloride (YL-0919)
por: Chang, Hai-Xia, et al.
Publicado: (2023)

Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression
por: Yang, Bangkun, et al.
Publicado: (2016)

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
por: Yang, C, et al.
Publicado: (2015)

The Ketamine Antidepressant Story: New Insights
por: Alshammari, Tahani K.
Publicado: (2020)

The antidepressant properties of ketamine (literature review)
por: Chamsi, F. Z., et al.
Publicado: (2023)

Acute Antidepressant Effects of Intramuscular Versus Intravenous Ketamine
por: Chilukuri, Harihar, et al.
Publicado: (2014)

The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication
por: Andrashko, Veronika, et al.
Publicado: (2020)

Author Correction: Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model
por: Zhang, Kai, et al.
Publicado: (2018)

Corrigendum: Essential role of microglia in the fast antidepressant action of ketamine and hypidone hydrochloride (YL-0919)
por: Chang, Hai-Xia, et al.
Publicado: (2023)

Correction: R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
por: Yang, C., et al.
Publicado: (2020)

Ketamine as Antidepressant? Current State and Future Perspectives
por: Hasselmann, H. W.W.
Publicado: (2014)

Ketamine: a new chapter in antidepressant development
por: Zarate, Carlos A.
Publicado: (2020)

Acute Antidepressant Effects of Intramuscular Versus Intravenous Ketamine: Erratum
Publicado: (2015)

The positive effect on ketamine as a priming adjuvant in antidepressant treatment
por: Melo, A, et al.
Publicado: (2015)

Hippocampal Perineuronal Nets Are Required for the Sustained Antidepressant Effect of Ketamine
por: Donegan, Jennifer J, et al.
Publicado: (2016)

Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
por: Cui, Meiying, et al.
Publicado: (2021)

Ketamine Alters Functional Plasticity of Astroglia: An Implication for Antidepressant Effect
por: Stenovec, Matjaž
Publicado: (2021)

Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb
por: Ma, Shuangshuang, et al.
Publicado: (2023)

Studying pre-treatment and ketamine-induced changes in white matter microstructure in the context of ketamine’s antidepressant effects
por: Sydnor, Valerie J., et al.
Publicado: (2020)

Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
por: Shirayama, Yukihiko, et al.
Publicado: (2017)

PS128. Ketamine R(-) and S(+) Pharmacological Actions; Together or Separate Rapid Acting Antidepressants
por: Domino, Edward F.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jripad7c39ubjlapb1bkqgjj4c